Jason Moran1, Rodrigo Ramirez-Campillo2, Urs Granacher3. 1. Department of Sport, Hartpury University, Gloucestershire, UK. jason.moran@hartpury.ac.uk. 2. Department of Physical Activity Sciences, Research Nucleus in Health, Physical Activity and Sport, Laboratory of Measurement and Assessment in Sport, Universidad de Los Lagos (University of Los Lagos), Osorno, Chile. 3. Division of Training and Movement Science, University of Potsdam, Potsdam, Germany.
Abstract
BACKGROUND: Jump training (JT) can be used to enhance the ability of skeletal muscle to exert maximal force in as short a time as possible. Despite its usefulness as a method of performance enhancement in athletes, only a small number of studies have investigated its effects on muscle power in older adults. OBJECTIVES: The aims of this meta-analysis were to measure the effect of JT on muscular power in older adults (≥ 50 years), and to establish appropriate programming guidelines for this population. DATA SOURCES: The data sources utilised were Google Scholar, PubMed, and Microsoft Academic. STUDY ELIGIBILITY CRITERIA: Studies were eligible for inclusion if they comprised JT interventions in healthy adults (≥ 50 years) who were free of any medical condition that could impair movement. STUDY APPRAISAL AND SYNTHESIS METHODS: The inverse variance random-effects model for meta-analyses was used because it allocates a proportionate weight to trials based on the size of their individual standard errors and facilitates analysis while accounting for heterogeneity across studies. Effect sizes (ESs), calculated from a measure of muscular power, were represented by the standardised mean difference and were presented alongside 95% confidence intervals (CIs). RESULTS: Thirteen training groups across nine studies were included in this meta-analysis. The magnitude of the main effect was 'moderate' (0.66, 95% CI 0.33, 0.98). ESs were larger in non-obese participants (body mass index [BMI] < 30 vs. ≥ 30 kg/m2; 1.03 [95% CI 0.34, 1.73] vs. 0.53 [95% CI - 0.03, 1.09]). Among the studies included in this review, just one reported an acute injury, which did not result in the participant ceasing their involvement. JT was more effective in programmes with more than one exercise (range 1-4 exercises; ES = 0.74 [95% CI - 0.49, 1.96] vs. 0.53 [95% CI 0.29, 0.78]), more than two sets per exercise (range 1-4 sets; ES = 0.91 [95% CI 0.04, 1.77] vs. 0.68 [95% CI 0.15, 1.21]), more than three jumps per set (range 1-14 jumps; ES = 1.02 [95% CI 0.16, 1.87] vs. 0.53 [95% CI - 0.03, 1.09]) and more than 25 jumps per session (range 6-200 jumps; ES = 0.88 [95% CI 0.05, 1.70] vs. 0.49 [95% CI 0.14, 0.83]). CONCLUSIONS: JT is safe and effective in older adults. Practitioners should construct varied JT programmes that include more than one exercise and comprise more than two sets per exercise, more than three jumps per set, and 60 s of recovery between sets. An upper limit of three sets per exercise and ten jumps per set is recommended. Up to three training sessions per week can be performed.
BACKGROUND: Jump training (JT) can be used to enhance the ability of skeletal muscle to exert maximal force in as short a time as possible. Despite its usefulness as a method of performance enhancement in athletes, only a small number of studies have investigated its effects on muscle power in older adults. OBJECTIVES: The aims of this meta-analysis were to measure the effect of JT on muscular power in older adults (≥ 50 years), and to establish appropriate programming guidelines for this population. DATA SOURCES: The data sources utilised were Google Scholar, PubMed, and Microsoft Academic. STUDY ELIGIBILITY CRITERIA: Studies were eligible for inclusion if they comprised JT interventions in healthy adults (≥ 50 years) who were free of any medical condition that could impair movement. STUDY APPRAISAL AND SYNTHESIS METHODS: The inverse variance random-effects model for meta-analyses was used because it allocates a proportionate weight to trials based on the size of their individual standard errors and facilitates analysis while accounting for heterogeneity across studies. Effect sizes (ESs), calculated from a measure of muscular power, were represented by the standardised mean difference and were presented alongside 95% confidence intervals (CIs). RESULTS: Thirteen training groups across nine studies were included in this meta-analysis. The magnitude of the main effect was 'moderate' (0.66, 95% CI 0.33, 0.98). ESs were larger in non-obeseparticipants (body mass index [BMI] < 30 vs. ≥ 30 kg/m2; 1.03 [95% CI 0.34, 1.73] vs. 0.53 [95% CI - 0.03, 1.09]). Among the studies included in this review, just one reported an acute injury, which did not result in the participant ceasing their involvement. JT was more effective in programmes with more than one exercise (range 1-4 exercises; ES = 0.74 [95% CI - 0.49, 1.96] vs. 0.53 [95% CI 0.29, 0.78]), more than two sets per exercise (range 1-4 sets; ES = 0.91 [95% CI 0.04, 1.77] vs. 0.68 [95% CI 0.15, 1.21]), more than three jumps per set (range 1-14 jumps; ES = 1.02 [95% CI 0.16, 1.87] vs. 0.53 [95% CI - 0.03, 1.09]) and more than 25 jumps per session (range 6-200 jumps; ES = 0.88 [95% CI 0.05, 1.70] vs. 0.49 [95% CI 0.14, 0.83]). CONCLUSIONS: JT is safe and effective in older adults. Practitioners should construct varied JT programmes that include more than one exercise and comprise more than two sets per exercise, more than three jumps per set, and 60 s of recovery between sets. An upper limit of three sets per exercise and ten jumps per set is recommended. Up to three training sessions per week can be performed.
Authors: Hubert Makaruk; Jason B Winchester; Jerzy Sadowski; Adam Czaplicki; Tomasz Sacewicz Journal: J Strength Cond Res Date: 2011-12 Impact factor: 3.775
Authors: Jason Moran; Gavin Sandercock; Rodrigo Ramirez-Campillo; Cain C T Clark; John F T Fernandes; Benjamin Drury Journal: Sports Med Date: 2018-07 Impact factor: 11.136
Authors: Rodrigo Ramirez-Campillo; Cristian Álvarez; Antonio García-Hermoso; Robinson Ramírez-Vélez; Paulo Gentil; Abbas Asadi; Helmi Chaabene; Jason Moran; Cesar Meylan; Antonio García-de-Alcaraz; Javier Sanchez-Sanchez; Fabio Y Nakamura; Urs Granacher; William Kraemer; Mikel Izquierdo Journal: Sports Med Date: 2018-05 Impact factor: 11.136
Authors: Rodrigo Ramirez-Campillo; Daniela Diaz; Cristian Martinez-Salazar; Pablo Valdés-Badilla; Pedro Delgado-Floody; Guillermo Méndez-Rebolledo; Rodrigo Cañas-Jamet; Carlos Cristi-Montero; Antonio García-Hermoso; Carlos Celis-Morales; Jason Moran; Thomas W Buford; Leocadio Rodriguez-Mañas; Alicia M Alonso-Martinez; Mikel Izquierdo Journal: Clin Interv Aging Date: 2016-12-13 Impact factor: 4.458
Authors: Rodrigo Ramirez-Campillo; David C Andrade; Pantelis T Nikolaidis; Jason Moran; Filipe Manuel Clemente; Helmi Chaabene; Paul Comfort Journal: J Sports Sci Med Date: 2020-08-13 Impact factor: 2.988
Authors: Sarah E Neil-Sztramko; Kylie Teggart; Caroline Moore; Diana Sherifali; Donna Fitzpatrick-Lewis; Giulia Coletta; Stuart M Phillips; K Bruce Newbold; Elizabeth Alvarez; Ayse Kuspinar; Courtney C Kennedy; Pasqualina L Santaguida; Rebecca Ganann Journal: BMC Geriatr Date: 2022-06-29 Impact factor: 4.070
Authors: Rodrigo Ramirez-Campillo; Daniel Castillo; Javier Raya-González; Jason Moran; Eduardo Sáez de Villarreal; Rhodri S Lloyd Journal: Sports Med Date: 2020-12 Impact factor: 11.136
Authors: Elena Pardos-Mainer; Demetrio Lozano; Marcelino Torrontegui-Duarte; Antonio Cartón-Llorente; Alberto Roso-Moliner Journal: Int J Environ Res Public Health Date: 2021-01-06 Impact factor: 3.390